Literature DB >> 35224012

Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication?

Ala I Sharara1, Maher Malaeb1, Matthias Lenfant2, Marc Ferrante2.   

Abstract

BACKGROUND: Endoscopic remission is an increasingly recognized important therapeutic endpoint in the management of patients with UC.
SUMMARY: The Mayo Endoscopic Score (MES) remains the most common endoscopic index recommended in guidelines and widely used in clinical trials and in clinical practice. The MES is easy, simple, and practical but is suboptimal at providing an accurate depiction of segmental healing and/or at measuring a substantial but incomplete response across the spectrum of endoscopic inflammation. Other endoscopic scores have been proposed but have not received wide recognition or adoption.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Endoscopy; Mayo Endoscopic Score; Mucosal healing; Ulcerative colitis

Year:  2021        PMID: 35224012      PMCID: PMC8820167          DOI: 10.1159/000518131

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  21 in total

Review 1.  A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

Authors:  Geert D'Haens; William J Sandborn; Brian G Feagan; Karel Geboes; Stephen B Hanauer; E Jan Irvine; Marc Lémann; Philippe Marteau; Paul Rutgeerts; Jurgen Schölmerich; Lloyd R Sutherland
Journal:  Gastroenterology       Date:  2006-12-20       Impact factor: 22.682

2.  The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis.

Authors:  Samuel Raimundo Fernandes; Patrícia Santos; Carlos Miguel Moura; Pedro Marques da Costa; Joana Rita Carvalho; Ana Isabel Valente; Cilénia Baldaia; Ana Rita Gonçalves; Paula Moura Santos; Luís Araújo-Correia; José Velosa
Journal:  Rev Esp Enferm Dig       Date:  2016-11       Impact factor: 2.086

3.  Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.

Authors:  Manuel Barreiro-de Acosta; Nicolau Vallejo; Daniel de la Iglesia; Laura Uribarri; Iria Bastón; Rocío Ferreiro-Iglesias; Aurelio Lorenzo; J Enrique Domínguez-Muñoz
Journal:  J Crohns Colitis       Date:  2015-09-07       Impact factor: 9.071

4.  Endoscopic and histological patchiness in treated ulcerative colitis.

Authors:  B Kim; J L Barnett; C G Kleer; H D Appelman
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

5.  Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.

Authors:  William J Sandborn; Chinyu Su; Bruce E Sands; Geert R D'Haens; Séverine Vermeire; Stefan Schreiber; Silvio Danese; Brian G Feagan; Walter Reinisch; Wojciech Niezychowski; Gary Friedman; Nervin Lawendy; Dahong Yu; Deborah Woodworth; Arnab Mukherjee; Haiying Zhang; Paul Healey; Julian Panés
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

6.  The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.

Authors:  Triana Lobatón; Talat Bessissow; Gert De Hertogh; Bart Lemmens; Chelsea Maedler; Gert Van Assche; Séverine Vermeire; Raf Bisschops; Paul Rutgeerts; Alain Bitton; Waqqas Afif; Victoria Marcus; Marc Ferrante
Journal:  J Crohns Colitis       Date:  2015-06-26       Impact factor: 9.071

7.  Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.

Authors:  Britt Christensen; Stephen B Hanauer; Jonathan Erlich; Olufemi Kassim; Peter R Gibson; Jerrold R Turner; John Hart; David T Rubin
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-24       Impact factor: 11.382

Review 8.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

9.  Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis.

Authors:  Ryan W Stidham; Wenshuo Liu; Shrinivas Bishu; Michael D Rice; Peter D R Higgins; Ji Zhu; Brahmajee K Nallamothu; Akbar K Waljee
Journal:  JAMA Netw Open       Date:  2019-05-03

10.  Central Reading of Ulcerative Colitis Clinical Trial Videos Using Neural Networks.

Authors:  Klaus Gottlieb; James Requa; William Karnes; Ranga Chandra Gudivada; Jie Shen; Efren Rael; Vipin Arora; Tyler Dao; Andrew Ninh; James McGill
Journal:  Gastroenterology       Date:  2020-10-21       Impact factor: 22.682

View more
  1 in total

Review 1.  How to assess endoscopic disease activity in ulcerative colitis in 2022.

Authors:  Mirko Di Ruscio; Marco Cedola; Manuela Mangone; Stefano Brighi
Journal:  Ann Gastroenterol       Date:  2022-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.